During the FDA advisory committee hearing on June 4, 2024, our founder & CEO, Cristina Pearse, urged the committee to save lives by approving MDMA-Assisted Therapy. Here is the full link to The New York Times article.
“Each day we postpone this therapy, I ask, at what cost? How many more people need to die before we approve an effective therapy? As you weigh the risks, please keep in mind the death rate for this understated population for perspective. This therapy can save many lives.
I’ve lost most of my life to this disease. I am grateful to reclaim it now but I wish this were an approved medication decades ago. Thank you.”
Andrew Jacobs is a Times reporter focused on how healthcare policy, politics and corporate interests affect people’s lives. More about Andrew Jacobs.
